Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Continue Reading

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

Continue Reading

CING studies ABT with the help of VarSome Clinical

Continue Reading

Building the best in variant classification

Continue Reading

Saphetor SA receives IVDR Certification for clinical diagnosis support NGS data analysis platform, VarSome Clinical, ensuring enhanced safety and performance standards

Continue Reading

Gene fusion detection: Liquid biopsies and classification of co-mutations

Continue Reading

Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Continue Reading

Company News listing page

By

Categories

Stay up to date

Picture of Xanthippi Papakonstanti

Xanthippi Papakonstanti

Community VarSome.com VarSome.com Premium VarSome in Action

Gene fusion detection: Liquid biopsies and classification of co-mutations
By Xanthippi Papakonstanti on April 5, 2024
0
Continue Reading

The Kingdom of Saudi Arabia has positioned genomic healthcare prominently in the Vision 2030 initiative, with a key focus on personalized healthcare. Saudi Arabia is actively sequencing its population’s genomes and tailoring treatments based on...

VarSome.com VarSome Clinical VarSome Team

Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare
By Xanthippi Papakonstanti on November 20, 2023
0
Continue Reading

Saphetor caught up with Constantia Aristidou from The Cyprus Institute of Neurology & Genetics (CING), that highlighted the breadth and scope of VarSome Clinical in their recently published paper; Exploring the Genetic Causality of Discordant...

Community VarSome.com VarSome Clinical VarSome in Action

CING studies ABT with the help of VarSome Clinical
By Xanthippi Papakonstanti on August 8, 2023
0
Continue Reading

We get a lot of great feedback on our classification tools. In particular, our germline classifier is a tool that healthcare professionals around the world constantly rely on to help them solve cases. This is because it implements recognized...

Technology VarSome API VarSome.com VarSome Clinical VarSome.com Premium ACMG

Building the best in variant classification
By Xanthippi Papakonstanti on May 16, 2023
4
Continue Reading

Aceragen, a biopharmaceutical company specializing in the development of treatments for rare genetic conditions, recently shared their novel approach to mapping Farber disease prevalence at ASHG 2022. Using VarSome Insights, the team were able to...

VarSome Insights

Aceragen Maps Rare Disease Prevalence with VarSome Insights
By Xanthippi Papakonstanti on March 2, 2023
0
Continue Reading

Submit a Comment

Stay up to date